Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA Randomized Clinical Trial
Targeting adenosine signaling in Parkinsons disease: from pharmacological to non-pharmacological approaches
Augmentation of the growth hormone axis in peripheral nerve injury
Xie D, Odronic SI, Wu F, Pippen AM, Donatucci CF, Annex BH
The safety boundaries that shape prescribing The class carries a boxed warning for thyroid C-cell tumor risk observed in rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
